Andrew Chow

17.2k citations

108 papers · 8.6k indexed · 5 hit papers · h-index 38

Impact in

Immunology top 0.5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Hematology top 1%
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 18
- Hematopoietic Stem Cell Transplantation 8
Immunology 32
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 8

Co-authors: Miriam Mérad Paul S. Frenette Douglas N. Fish Daigo Hashimoto Melanie Greter Emmanuel L. Gautier Daniel Lucas Karlo Perica
Journals: The Journal of Clinical Pharmacology (11 papers)Antimicrobial Agents and Chemotherapy (10 papers)Clinical Pharmacokinetics (7 papers)Blood (5 papers)The Journal of Immunology (5 papers)
Partner nations: United States Canada Japan

In The Last Decade

Andrew Chow

104 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories log scale

Clinical implications of T cell exhaustion for cancer immunotherapy 2022 · 559 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Reviews Clinical Oncology
2014 Cell Host & Microbe
2012 Nature Immunology
2012 Nature Immunology
2011 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Andrew Chow

Since Specialization

Citations

This map shows the geographic impact of Andrew Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Chow more than expected).

Fields of papers citing papers by Andrew Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Chow. The network helps show where Andrew Chow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Chow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Chow Line = papers co-authored together Andrew Chow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector Nature Communications ·Nicholas Ceglia, Zachary Sethna, Samuel S. Freeman, Florian Uhlitz, Viktoria Bojilova, Nicole Rusk, Xu Cheng, Andrew Chow, Sohrab Salehi, Farhia Kabeer, Samuel Aparício, Benjamin D. Greenbaum, Sohrab P. Shah, Andrew McPherson	2023	4
2	Spontaneous Bilateral Chylothorax Development During Alectinib Therapy for ALK-Rearranged NSCLC—A Case Report JTO Clinical and Research Reports ·Stanisław Liszka, Andrew Chow, Alexander Drilon, Or Kalchiem‐Dekel	2023	2
3	WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC Cell Reports ·Hirokazu Taniguchi, Rebecca Caeser, Shweta S. Chavan, Yingqian A. Zhan, Andrew Chow, Parvathy Manoj, Fathema Uddin, Hidenori Kitai, Rui Qu, Omar Hayatt, Nisargbhai Shah, Natalia N. Nielsen, Viola Allaj, Evelyn M. Nguyen, Joseph M. Chan, Adam O. Michel, Hiroshi Mukae, Elisa de Stanchina, Charles M. Rudin, Triparna Sen	2022	81
4	Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seq STAR Protocols ·Àlvaro Quintanal-Villalonga, Joseph M. Chan, Ignas Masilionis, Vianne R. Gao, Yubin Xie, Viola Allaj, Andrew Chow, John T. Poirier, Dana Pe’er, Charles M. Rudin, Linas Mažutis	2022	3
5	Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models Cancer Research ·Sai Kiran Sharma, Andrew Chow, Sébastien Monette, Delphine Vivier, Jacob Pourat, Kimberly J. Edwards, Thomas R. Dilling, Dalya Abdel-Atti, Brian M. Zeglis, John T. Poirier, Jason S. Lewis	2018	81
6	Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry BMJ Open ·Proton Rahman, Michel Zummer, Louis Bessette, Bérengère Deffrennes, Boulos Haraoui, Andrew Chow, Katalin Burom, Pande Nyoman Ariyuda Semadi, Emmanouil Rampakakis, Eliofotisti Psaradellis, A.J. Lehman, F. Nantel, B. Osborne, C. Tkaczyk	2017	22
7	Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis Clinical Pharmacokinetics ·Ping Chen, Avani Desai, Benjamin Wu, Per Olsson, John P. Gibbs, Andrew Chow, Murad Melhem	2017	7
8	Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study The Open Rheumatology Journal ·Carter Thorne, Gilles Boire, Andrew Chow, Guangli Ren, Fang Liu, Melanie Poulin-Costello, Valery Walker, Boulos Haraoui	2017	4
9	Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis BMJ Open ·Proton Rahman, D. Choquette, W. Bensen, Majed Khraishi, Andrew Chow, Michel Zummer, 谷茂春, キイチロウコバヤシ, Sanjay Dixit, Young Jin Lee, Eliofotisti Psaradellis, John S. Sampalis, Riad M. Nasser, A.J. Lehman, F. Nantel, Emmanouil Rampakakis, Van Damme W, M. Shawi	2016	12
10	Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications Clinical Pharmacokinetics ·Min Zhu, Benjamin Wu, Christian Brandl, Jessica Johnson, Andreas Wolf, Andrew Chow, Sameer Doshi	2016	157
11	Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche The Journal of Experimental Medicine ·Andrew Chow, Daniel Lucas, Andrés Hidalgo, Simón Méndez‐Ferrer, Daigo Hashimoto, Christoph Scheiermann, Michela Battista, Marylène Leboeuf, Colette Prophete, Nico van Rooijen, Masato Tanaka, Miriam Mérad, Paul S. Frenette Hit paper breakdown →	2011	625
12	Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation The Journal of Experimental Medicine ·Daigo Hashimoto, Andrew Chow, Melanie Greter, Yvonne M. Saenger, W. H. Kwan, Marylène Leboeuf, Florent Ginhoux, Jordi Ochando, Yuya Kunisaki, Nico van Rooijen, Chen Liu, Takanori Teshima, Peter S. Heeger, E. Richard Stanley, Paul S. Frenette, Miriam Mérad	2011	122
13	Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis Clinical Pharmacokinetics ·Liviawati Sutjandra, A. Sukhanov, Sameer Doshi, Mark Ma, Mark Peterson, Graham Jang, Andrew Chow, Juan José Pérez Ruixo	2011	87
14	Ethical considerations for normal control subjects in MRI research Journal of Clinical Neuroscience ·Andrew Chow, Katharine J. Drummond	2010	2
15	Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects The AAPS Journal ·Yow‐Ming Wang, Wojciech Krzyżański, Sameer Doshi, Jim Xiao, Juan José Pérez Ruixo, Andrew Chow	2010	68
16	Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors The Journal of Clinical Pharmacology ·Peiming Ma, Bingbing Yang, Yow‐Ming Wang, Mark Peterson, Avani Desai, Liviawati Sutjandra, A. Sukhanov, Andrew Chow	2009	69
17	Exposure‐toxicity relationships for tipifarnib in cancer patients British Journal of Clinical Pharmacology ·Juan José Pérez Ruixo, Wei Chen, Steven Zhang, R Apéry, Andrew Chow	2007	4
18	Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity The Journal of Immunology ·Teresa Ramirez‐Montagut, Andrew Chow, Daniel Hirschhorn-Cymerman, Theis H. Terwey, Adam A. Kochman, Sydney X. Lu, V. G. Takalkar, Shimon Sakaguchi, Alan N. Houghton, Marcel R.M. van den Brink	2006	141
19	Population Cell Life Span Models for Effects of Drugs Following Indirect Mechanisms of Action Journal of Pharmacokinetics and Pharmacodynamics ·Juan José Pérez Ruixo, Hui C. Kimko, Andrew Chow, Vladimir Piotrovsky, Wojciech Krzyżański, William J. Jusko	2005	29
20	Update to the PhRMA Perspective on Population and Individual Bioequivalence The Journal of Clinical Pharmacology ·Jeffrey S. Barrett, Vijay Batra, Andrew Chow, Jack Cook, A. Lawrence Gould, Allen H. Heller, Man‐Wai Lo, Scott D. Patterson, Brian P. Smith, seizo Uchida, José M. Vega, Névine Zariffa	2000	5

About Andrew Chow

Andrew Chow is a scholar working on Hematology, Immunology, Molecular Medicine, Oncology and Pharmacology, having authored 108 papers that have together received 8.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (11 papers), Rheumatoid Arthritis Research and Therapies (9 papers), T-cell and B-cell Immunology (8 papers), Hematopoietic Stem Cell Transplantation (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Pneumonia and Respiratory Infections (7 papers). The work is most often cited by research in Immunology (4.1k citations), Hematology (1.0k citations), Molecular Medicine (433 citations), Neurology (613 citations) and Oncology (1.7k citations). Andrew Chow has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Miriam Mérad, Paul S. Frenette, Douglas N. Fish, Daigo Hashimoto, Melanie Greter, Emmanuel L. Gautier, Daniel Lucas, Karlo Perica, Jedd D. Wolchok and Christopher A. Klebanoff. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Pharmacokinetics, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact